Search research articles
Contact Us
Filters
Showing results (71-80 of 83) with videos related to
Page
of 9
Sort By:
Archives of Otolaryngology (Chicago, Ill. : 1960)
|
April 1, 1984
Advanced squamous carcinoma of the head and neck. A preliminary report of neoadjuvant chemotherapy with cisplatin, bleomycin, and methotrexate
T J Ervin, R R Weichselbaum, R L Fabian, et al.
International Journal of Radiation Oncology, Biology, Physics
|
November 1, 1985
Treatment complications after sequential combination chemotherapy and radiotherapy with or without surgery in previously untreated squamous cell carcinoma of the head and neck
M R Posner, R R Weichselbaum, T J Fitzgerald, et al.
Blood
|
May 1, 1992
Human bone marrow depleted of CD33-positive cells mediates delayed but durable reconstitution of hematopoiesis: clinical trial of MY9 monoclonal antibody-purged autografts for the treatment of acute myeloid leukemia
M J Robertson, R J Soiffer, A S Freedman, et al.
Seminars in Oncology
|
June 1, 1988
Chemotherapeutic strategies in the multidisciplinary treatment of head and neck cancer
J R Clark, B G Fallon, A I Dreyfuss, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 1, 1987
An analysis of induction and adjuvant chemotherapy in the multidisciplinary treatment of squamous-cell carcinoma of the head and neck
T J Ervin, J R Clark, R R Weichselbaum, et al.
International Journal of Radiation Oncology, Biology, Physics
|
December 1, 1993
Is a surgical resection leaving positive margins of benefit to the patient with locally advanced squamous cell carcinoma of the head and neck: a comparative study using the intergroup study 0034 and the Radiation Therapy Oncology Group head and neck database
G E Laramore, C B Scott, D E Schuller, et al.
International Journal of Radiation Oncology, Biology, Physics
|
January 1, 1992
Adjuvant chemotherapy for resectable squamous cell carcinomas of the head and neck: report on Intergroup Study 0034
G E Laramore, C B Scott, M al-Sarraf, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
September 9, 2011
A randomized phase II trial of pemetrexed/gemcitabine/bevacizumab or pemetrexed/carboplatin/bevacizumab in the first-line treatment of elderly patients with advanced non-small cell lung cancer
David R Spigel, John D Hainsworth, Dianna L Shipley, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 9, 2013
Randomized phase II trial of Onartuzumab in combination with erlotinib in patients with advanced non-small-cell lung cancer
David R Spigel, Thomas J Ervin, Rodryg A Ramlau, et al.
The New England Journal of Medicine
|
October 26, 2007
Cisplatin and fluorouracil alone or with docetaxel in head and neck cancer
Marshall R Posner, Diane M Hershock, Cesar R Blajman, et al.
Page
of 9
Search research articles
Search
Showing results (71-80 of 83) with videos related to
Sort By:
Page
of 9
Archives of Otolaryngology (Chicago, Ill. : 1960)
|
April 1, 1984
Advanced squamous carcinoma of the head and neck. A preliminary report of neoadjuvant chemotherapy with cisplatin, bleomycin, and methotrexate
T J Ervin, R R Weichselbaum, R L Fabian, et al.
International Journal of Radiation Oncology, Biology, Physics
|
November 1, 1985
Treatment complications after sequential combination chemotherapy and radiotherapy with or without surgery in previously untreated squamous cell carcinoma of the head and neck
M R Posner, R R Weichselbaum, T J Fitzgerald, et al.
Blood
|
May 1, 1992
Human bone marrow depleted of CD33-positive cells mediates delayed but durable reconstitution of hematopoiesis: clinical trial of MY9 monoclonal antibody-purged autografts for the treatment of acute myeloid leukemia
M J Robertson, R J Soiffer, A S Freedman, et al.
Seminars in Oncology
|
June 1, 1988
Chemotherapeutic strategies in the multidisciplinary treatment of head and neck cancer
J R Clark, B G Fallon, A I Dreyfuss, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 1, 1987
An analysis of induction and adjuvant chemotherapy in the multidisciplinary treatment of squamous-cell carcinoma of the head and neck
T J Ervin, J R Clark, R R Weichselbaum, et al.
International Journal of Radiation Oncology, Biology, Physics
|
December 1, 1993
Is a surgical resection leaving positive margins of benefit to the patient with locally advanced squamous cell carcinoma of the head and neck: a comparative study using the intergroup study 0034 and the Radiation Therapy Oncology Group head and neck database
G E Laramore, C B Scott, D E Schuller, et al.
International Journal of Radiation Oncology, Biology, Physics
|
January 1, 1992
Adjuvant chemotherapy for resectable squamous cell carcinomas of the head and neck: report on Intergroup Study 0034
G E Laramore, C B Scott, M al-Sarraf, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
September 9, 2011
A randomized phase II trial of pemetrexed/gemcitabine/bevacizumab or pemetrexed/carboplatin/bevacizumab in the first-line treatment of elderly patients with advanced non-small cell lung cancer
David R Spigel, John D Hainsworth, Dianna L Shipley, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 9, 2013
Randomized phase II trial of Onartuzumab in combination with erlotinib in patients with advanced non-small-cell lung cancer
David R Spigel, Thomas J Ervin, Rodryg A Ramlau, et al.
The New England Journal of Medicine
|
October 26, 2007
Cisplatin and fluorouracil alone or with docetaxel in head and neck cancer
Marshall R Posner, Diane M Hershock, Cesar R Blajman, et al.
Page
of 9